FDA issued a Warning Letter to Pharmalucence, Inc. on 9/23/2008 as a result of this inspection.
483 Pharmalucence Apr 2008

483 Pharmalucence Apr 2008

Megan Haggerty FDA$119.00 - Available Now

FDA investigators audited the Pharmalucence - Bedford, MA, United States facility and issued inspectional observations (via FDA 483) on 30 Apr 2008.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Apr 2008
  • Location: Bedford, United States
  • FEI: 1219718
Add To Cart